A new Beginning..., page-2284

Pilko3 I hope you are right with  all your assumptions. Firstly it is very unhealthy to compare a tiddler like RAP to Cochlear. Remember RAP
is a diagnosis not a treatment. This company will never get near $20 as  we all agree in will need a  very large revenue and  if this occurs we have heard many times it will be embedded into a major telehealth company. The telehealth major would T/O rather than pay an ongoing never ending licence fee. The top 20 will decide the fate of this company and if it ever gets to 55c{its highest point ever} they will be looking at the exit. Sorry but as small shareholders  we will never decided the fate  of this company. Remember  management if  there is  a T/O , 93 m performance will be a
triggered which will give 8 people a chance to retire early.